Moderna Shares Surge on Bird Flu Death and COVID-19 Spike
Moderna's stock jumped nearly 12% following the first US bird flu death and rising COVID-19 cases. Learn more about the factors impacting Moderna's rise.
Moderna surged nearly 12% after the first US bird flu death and an uptick in COVID-19 cases.